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Abstract
Background: The increasing number of patients with implantable cardioverter-defibrillators (ICD) 
contributes to the rising number of patients qualifying for a transvenous lead extraction (TLE) due 
to infection, vascular or lead failure related indications. The purpose of this study was to perform  
a retrospective analysis of the occurrence of conductor externalization in TLE patients and to assess the 
success rate in the extraction of these leads. 
Methods: TLE procedure was performed between 2012 and 2014 of 428 electrodes in 259 patients. 
Out of these, 143 (33.4%) leads in 138 (52.9%) patients were  ICD leads. The indications for the TLE 
in ICD patients were: infection in 37 patients, lead failure in 84 patients, and others in 17 patients. 
Conductor externalization was observed in 8 ICD leads (5.6%) in 8 (5.8%) patients. The mean dwell-
ing time for externalized leads was 87.9 (55 to 132) months compared to 60.1 (3 to 246) months of the 
remaining 135 ICD leads (p = 0.0329). All externalized leads were successfully and completely extracted 
using device traction, mechanical telescopic sheaths and/or autorotational cutting sheaths. No complica-
tions of  lead extraction procedures were observed in 8 patients with externalization.
Results: Patients with lead externalization were often in a better New York Heart Association func-
tional class (I or II) compared to those in the rest of the study group (p = 0.0212). 
Conclusions: Conductor externalization is a rare finding in patients undergoing TLE. This occurs 
with different manufacturers and lead types. In this complication transvenous lead extraction with the 
mechanical extraction tools can be safely performed. (Cardiol J 2018; 25, 2: 221–228)
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Introduction
Currently, patients are more often and more 
eagerly qualified for transvenous lead extraction 
(TLE) procedures because of their high effective-
ness and low complication rate [1, 2]. Moreover, 
there is a growing number of patients with implant-
able cardioverter-defibrillator (ICD) leads that 
need to be extracted mostly due to non-infectious 
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tors, insulation as well as the device connectors) is 
prone to failure [4]. The specific type of ICD lead 
damage is the externalization of internal conductor. 
An externalization of inner conductors seems pos-
sible in each lead with multi-tunnel construction, 
however, its occurrence is more likely in certain 
types of leads. It depends not only on the material 
type of  outerhigh-voltage cables, construction and 
localization of the inner tunnels in the lead but also 
on the tension occurring on the lead [5]. 
The purpose of the study was to perform 
a retrospective analysis of the occurrence of con-
ductor externalization among patients undergoing 
transvenous lead extraction procedure. Extraction 
success rate of these leads was also analyzed. 
The project was approved by the Bioethics 
Committee of Institute of Cardiology and complies 
with the Declaration of Helsinki.
Methods
In years 2012–2014, the procedure of TLE 
was performed in 259 patients at the Institute of 
Cardiology in Warsaw. A total of 428 leads were 
extracted, out of which 143 (33.4%) in 138 (52.9%) 
patients were defibrillator leads. The indications 
for extraction in ICD patients were: a device-
related infection in 37 patients and lead failure in 
84 patients. Other indications including late perfo-
ration (4 patients), occlusion of the venous system 
with the aim of regaining venous access (7 patients) 
or lead dislocation (6 patients) were also observed. 
The lead failure was defined as an electric failure 
with noise leading to inappropriate shocks, as well 
as changes in the lead threshold, impedance, and/or 
sensing parameters. Clinical and device informa-
tion especially concerning defibrillator leads ex-
ternalization were obtained from our database of 
TLE procedures. Additional data were retrieved 
from clinical records. General demographic data 
was also collected. Clinical characteristics of the 
study group is shown in Table 1.
Pacing malfunctions were observed in 7 (5.1%) 
patients with ICD lead failure and high-voltage cir-
cuit malfunctions were noted in 6 (4.3%) patients. 
71 (51.4%) patients, including all with externaliza-
tions, were diagnosed with both pacing and sensing 
malfunctions including an inappropriate detection 
of ventricular arrhythmias but without notable 
high-voltage circuit malfunction.
The routine management before the TLE 
procedure contained 2-dimensional radiological 
evaluation or fluoroscopic evaluation aiming to 
identify all implanted leads, their fixation mode, 
localization and integrity. Cine fluoroscopy was 
performed in right anterior oblique, posteroan-
terior and left anterior oblique projections. Lead 
conductor externalization was defined as the ap-
Table 1. Clinical characteristics of  patients with and without conductor externalization in implantable 
cardioverter-defibrillators leads (number of patients: 138).
Conductors’ non-externalized  
(n = 130)
Conductors’ externalized  
(n = 8)
P
Patient age [years] 57.7 ± 14.6 53.8 ± 20.0 NS
Sex (male) 98 (75.4%) 6 (75%) NS
NYHA class during surgery: 0.0212
I and II 74 (57%) 8 (100%)
III and IV 56 (43%) 0 (0%)
Main diagnosis: NS
Coronary artery disease 62 (47.7%) 4 (50%)
Dilated cardiomyopathy 36 (27.6%) 0 (0%)
Hypertrophic cardiomyopathy 14 (10.9%) 3 (37.5%)
Other diagnosis 18 (13.8%) 1(12.5%)
Indication for extraction:
Infection 37 (28.5%) 0 (0%) NS
Lead failure 76 (58.4%) 8 (100%) 0.0210
Other indications 17 (13.1%) 0 (0%) NS
NYHA — New York Heart Association; Other diagnosis: idiopathic ventricular fibrillation, long QT syndrome, arrhythmogenic right ventricular 
cardiomyopathy, cathecholaminergic polymorphic ventricular tachycardia, idiopathic ventricular tachycardia, Danon disease, congenital and 
acquired heart defect
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pearance of conductors outside the lead body on 
fluoroscopy or X-ray picture in any of the views. 
Such radiologic evaluation allowed proper detec-
tion of externalizations in defibrillator leads in 
8 patients (Fig. 1).
Each lead extraction procedure performed was 
due to non-infectious indications and was combined 
with concurrent implantation of a new system, 
except for 1 patient who had thoracotomy. In the 
case of infectious indications, the implantation of 
a new system was postponed until infection was 
eliminated.
Due to the complexity and possible complica-
tions the procedures were carried out in hybrid 
operating room conditions in order to provide 
complete cardiothoracic backup as well as general 
anesthesia safety. The extractions were performed 
under fluoroscopy. 
Lead extraction techniques were introduced 
gradually, starting from the less invasive to the 
more advanced, that is from a simple traction 
through device traction and, finally with the use 
of mechanical systems. Radiological and clinical 
success of the procedure was defined as in the 
literature [1].  
Device traction was used most frequently. It 
was performed with the use of steel or polypropyl-
ene mechanical telescopic sheaths (Cook Vascular, 
Leechburg, PA, USA) rotated manually along the 
lead to dissect adhesions to the vascular system. 
Sheath diameter depended on the lead diameter 
and was changed for a bigger one if there were any 
difficulties in covering all lead elements as well as 
adhesions around it with the sheath. The biggest 
available diameter (13 F) was applied a priori for 
the leads with visible externalization, what enabled 
covering the lead body with externalized cables and 
potential cable adhesions. If required, the use of 
a standard stylet or locking stylet Liberator Beacon 
Tip (Cook Vascular, Leechburg, PA, USA) helped 
to ensure the stiffness of the leads with preserved 
internal lumen. The stiff connection of all parts of 
an extracted lead is, in general, a key issue for the 
success and safety of a procedure, however, it is 
of the utmost importance in the case of leads with 
externalization. This was obtained with the use of 
a tight self-locking knot. 
Moreover, in 1 patient, the ‘Bulldog’ Lead Ex-
tender (Cook Vascular, Leechburg, PA, USA) was 
used beside the locking stylet in order to preserve 
traction on externalized conductors.
In patients with massive adhesions or calcifi-
cations which could not be separated by means of 
manually rotated sheaths, the mechanical autoro-
Figure 1. Fluoroscopic evaluation of Kainox RV lead, 
dwelling time 126 months.
tating ‘Evolution’ system (Cook Vascular, Leech-
burg, PA, USA) was used. For the electrodes with 
visible externalization, as in the case of telescopic 
sheaths, the Evolution system with the maximum 
available dimension (that is 13 F) was used.
The extracted electrodes were evaluated 
by macroscopic examination in order to prove 
externalizations and detect hematin deposits in 
the leads. Contrary to acute damage when only 
fresh blood occurs in the lead body, the hematin 
deposits indicate various levels of the insulation 
damage before the TLE procedure (Fig. 2). The 
leads extracted during the last 6 months were as-
sessed usingmicroscopic examination to confirm 
externalization and to determine the extent of the 
damage. Endocardial leads were analyzed with an 
optical microscope with  0.5–4.0 × magnification 
and all abnormalities of the outermost insulation 
coating were photographed (Fig. 3).
Statistical analysis
Statistical analysis was performed with the 
SAS 8.2 statistical package (SAS, Institute Inc, 
Cary, NC, USA). The results are presented in the 
form of arithmetic means and standard deviations 
of quantity attributes or as the frequency and 
percentage of the distinguished units of nominal 
features. The study of nominal variables involved 
using contingency tables, and the distribution of 
features were analysed first by the Pearson c2 test. 
In cases where the expected value of the observa-
tion in the cell was less than 5, the Fisher exact test 
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was additionally used. The Shapiro-Wilk test veri-
fied the compliance of distribution of continuous 
variables with a normal distribution. To compare 
the significance of differences occurring between 
mean values, depending on the homogeneity or 
heterogeneity of variance, the t-test or Cochran-
Cox test were used respectively. Verifications of 
null hypotheses were carried out assuming the 
level of statistical significance a £ 0.05.
Results
Among the 143 extracted defibrillator leads 
externalization was identified before the TLE pro-
cedure in 8 (5.6%) defibrillator leads in 8 (5.8%) 
patients, namely (time from implantation to the 
extraction is given in brackets and expressed in 
months): one Kainox RV (Biotronik Berlin Ger-
many) (126 months), one Linox (Biotronik Berlin 
Germany) (57 months), one SPL (Ventritex — St. 
Jude Medical Inc. Sylmar, CA, USA) (132 months), 
one Riata ST (St. Jude Medical Inc. Sylmar, CA, 
USA) (71 months) and four Riata (St. Jude Medi-
cal Inc. Sylmar, CA, USA) (96, 93, 73, 55 months, 
respectively) leads (Table 2). 
Patients with the lead externalization were of-
ten in better New York Heart Association (NYHA) 
functional class (I or II) compared with the rest of 
the study group (p = 0.0212). An electrical lead 
failure occurred more frequently in this group 
(p = 0.0210). However, there were no differences 
in the mean age, sex or underlying heart disease 
(Table 1).
The clinical success of the TLE was obtained 
in all patients from the analyzed group. All exter-
nalized electrodes were completely removed. Out 
of 135 leads without externalization, 132 (97.7%) 
leads were extracted entirely and in 3 patients 
electrode fragments shorter than 4 cm were left. 
The mechanical autorotating system was used 
in 1 (12.5%) patient with externalization and 17 
(13.1%) out of 130 remaining patients (p = NS). 
The mean dwelling time for externalized leads 
(8 cases) equaled 87.9 months (55–132) and was lon-
ger in comparison to the rest of the ICD leads (135 
leads) — 60.1 months (3–246) (p = 0.0329). Pas-
sive fixation leads were more common in the group 
with externalization (75% vs. 17%; p < 0.001). 
The number of either all or high-voltage only leads 
implanted in a particular patient, single or dual coil 
lead construction and type of implanted device had 
no influence on increased incidence of externaliza-
tion (Table 3).
Data concerning the types of implanted leads 
were available for 101 patients from the study 
group (Table 3). For the patient implanted out-
side of the center herein, not all of the data about 
leads were possible to obtain. Out of allavailable 
lead types only the lead from the Riata family had 
a greater incidence of externalization. 
During the last 6 months of the study optical 
microscope analysis of leads confirms inside-out 
insulation abrasion in 2 out 25 leads (Fig. 3). 
No complications of the lead extraction proce-
dure were observed in 8 patients with externaliza-
tion. In the remaining 130 patients, complications 
occurred in 4 patients (p = NS). There were 
two major complications (1.6%), one tamponade, 
treated surgically and one breakage of a polypro-
pylene telescopic sheath used for TLE, which 
also required thoracotomy for its removal. Minor 
complications were observed in 2 (1.6%) patients: 
a case of femoral artery embolism treated with an 
embolectomy and 1 case of a massive hematoma 
which required non-invasive treatment and pro-
longed hospitalization. Additionally, in 2 patients 
Figure 2. Macroscopic evaluation after extraction; A. Riata 
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Table 2. Type of extracted implantable cardioverter-defibrillators leads (101 available)






Riata ST St. Jude Medical Inc. Sylmar, CA, USA 4 (80%) 1 (20%)
Riata St. Jude Medical Inc. Sylmar, CA, USA 4 (50%) 4 (50%)
Durata St. Jude Medical Inc. Sylmar, CA, USA 15 (100%) 0 (0%)
Linox family Biotronik Berlin Germany 30 (96.8%) 1 (3.2%)
Kainox Biotronik Berlin Germany 4 (80%) 1 (20%)
SPS Biotronik Berlin Germany 3 (100%) 0 (0%)
Sprint Quarto Medtronic Minneapolis, USA 17 (100%) 0 (0%)
Sprint Medtronic Minneapolis, USA 2 (100%) 0 (0%)
Fidelis Medtronic Minneapolis, USA 6 (100%) 0 (0%)
TVL Ventritex — St. Jude Medical Inc. Sylmar, CA, USA 5 (100%) 0 (0%)
SPL Ventritex — St. Jude Medical Inc. Sylmar, CA, USA 3 (75%) 1 (25%)
Figure 3. Optical microscope analyze of transvenously removed implantable cardioverter-defibrillator leads with con-
ductor exposure; A, B. Linox lead; C, D. SPL lead; A–F. Hematine deposits; A–D. Cable externalization.
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there were complications of new implantations 
including implantable cardioverter-defibrillators 
with resynchronization therapy (CRT-D) implanta-
tion on the opposite side of the chest related to an 
inability to regain access from the side of extracted 
leads and the atrial lead repositioning in another 
patient before discharge from the hospital.
Discussion
In the presented database information was 
found concerning SPL (Ventritex — St. Jude 
Medical Inc. Sylmar, CA, USA) and Kainox (Bio-
tronik, Berlin, Germany) lead externalization 
was not widely known in literature previously. 
Until recently, the occurrence of externalization 
was mainly described in the context of Riata (St. 
Jude Medical Inc. Sylmar, CA, USA) leads. The 
latest reports indicate, however, the possibility 
of externalization occurrence in Linox (Biotronik, 
Berlin, Germany) and Kentrox (Biotronik, Berlin, 
Germany) leads [6–8]. In observance of this, the 
fluoroscopic evaluation seems to be necessary in 
wider populations and not only with leads under 
advisory [9]. 
Externalization was observed more often 
in older and passive fixation leads in individuals 
with lower NYHA. These observations are in line 
with other evidence [10–12]. A factor which may 
explain this is heart contraction strength which 
may additionally have an influence on intracardiac 
movement of the electrode. Also the fact that some 
of the externalized leads had been implanted ap-
proximately 10 years ago and was most probably 
the reason why passive fixation leads were more 
frequent in this group. At present, the tendancy is 
to use active fixation leads.
Some electrical parameters in the externalized 
electrodes, such as R wave value, may be suscepti-
ble to interference, whereas other parameters usu-
ally stay unaltered. The rate of completely faulty 
leads remains low [13, 14]. In the present group 
high voltage circuit failure stayed low, however 
the response of such leads during high-voltage 
intervention and measurements conducted with 
low-voltage current do not provide any clear-cut 
answers [15]. The hitherto conducted analyses 
suggest that further damage of externalized leads 
might occur during high-voltage intervention and 
therefore result in a short-circuit which would 
mean unsuccessful intervention. However, such 
leads might not demonstrate any failure signs 
beforehand [16, 17]. In this group with conductor 
externalization lead failure, pacing and sensing 
malfunction were the first sign and indication for 
lead extraction. 
Microscopic evaluation showing insulation 
damage with hematin deposit may influence the 
Table 3. Clinical characteristics of the leads with conductor externalization (number of leads: 143).
Conductors’ non-externalized  
(n = 135)
Conductors’ externalized  
(n = 8)
P
Lead age [months] 60.1 ± 43.8 87.9 ± 29.4 0.0329
Passive fixation 23 (17%) 6 (75%)   < 0.001
Single-coil lead 80 (59.3%) 3 (37.5%) NS
Number of implanted leads (during extraction): NS
1 66 (48.9%) 7 (87.5%)
> 1 69 (51.1%) 1 (12.5%)
Number of implanted ICD leads (during extraction): NS
1 126 (96.9%) 7 (87.5%)
2 4 (3.1%) 1 (12.5%)
Device type: NS
CRT-D 31 (27.4%) 0 (0%)
ICD-DR 53 (39.3%) 2 (25%)
ICD-VR 45 (33.3%) 6 (75%)
Lead type (101 — 70.6% available) < 0.005
Riata lead 8 (61.5%) 5 (38.5%)
Other 85 (95.6%) 3 (4.4%)
ICD — implantable cardioverter-defibrillator; ICD-VR —  single chamber ICD; ICD-DR — dual chamber ICD; CRT-D — ICD with resynchroniza-
tion therapy
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decision to qualify to TLE more urgently. Faulty 
leads can promote thrombus formation and em-
bolism as well as bacterial colonization leading to 
infective endocarditis [18–20]. In this population 
no externalization was found in microscopic evalu-
ation and negative in fluoroscopic assessment but 
the number of leads evaluated is relatively low.  
The presented lead extraction efficacy con-
cerning electrodes with conductor externalization 
and other leads as well as ICD leads under advi-
sory seems to be similar to that presented in the 
literature [1, 21–23]. The use of additional tools in 
order to provide supplementary traction on the ex-
ternalized cables when necessary guarantees more 
efficient and safer performance of the procedure 
[21–24]. For this purpose, in one patient from the 
group a ‘Bulldog’ Lead Extender was used apart 
from the typical locking stylet. A self-tightening 
knot was used that secured lead integrity and pos-
sibility of traction on each of its elements. How-
ever, specific systems dedicated to that function 
are commercially available at present. In the case 
of leads with an externalization, telescopic sheaths 
and ‘Evolution’ system with the maximum avail-
able diameter were used in the presented center, 
enabling covering not only the lead body but also 
externalized cables and potential cable adhesions. 
These tools are sufficient to provide successful and 
safe TLE in leads with externalization. 
Limitations of the study
The retrospective character of the present 
study contributed mainly to the study limitations. 
The small number of patients limited the possibil-
ity of revealing either externalization risk factors 
or occurrence of rare TLE complications. The 
lack of the data concerning the diameter of ap-
plied telescopic sheaths, the remaining lead types, 
fluoroscopy and the course of the procedures made 
it impossible to conduct more precise analyses. 
Finally, the exclusive use of mechanical extraction 
tools may be another limitation concerning the ex-
traction techniques used in the studied population. 
Conclusions
Conductor externalization is a rare finding in 
patients undergoing TLE. This occurs with differ-
ent manufacturers and lead types. In this complica-
tion TLE with the mechanical extraction tools can 
be safely performed.
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